Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors
Clinical trial NCT01401504 · COMPLETED
Trial details
- NCT number
- NCT01401504
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2014-01-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.